The findings from HCC patients are consistent with preclinical pharmacology studies in N1S1 HCC tumor-bearing rats, in which overexpression of A3AR in the tumor tissue was reflected in the PBMCs of the animals [42]. This evidence concerns the gene ADORA3 and hepatocellular carcinoma.